Developers are shifting toward artificial intelligence infrastructure as blockchain ecosystems lose contributors across major networks, from Ethereum to Solana.

Generate:Biomedicines (NASDAQ: GENB), the drug developer focused on creating immunology and inflammation (I&I) and oncology treatments through its own artificial intelligence (AI)-based platform, has ...

This week’s software-stock selloff feels like the latest reason to reach for the career panic button, unless you happen to be an artificial-intelligence developer. Investors are dumping shares of ...

There was huge news last week in the colliding worlds of copyright protection and development of artificial intelligence. The artificial intelligence developer, Anthropic, recently settled a very high ...

While elites tell us we need to fear artificial intelligence, they continue to approve of the Federal Reserve’s attempts to expand artificial credit, which is ...